(−)-BM 13.0913: A new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non—insulin-dependent) diabetes mellitus
- 31 May 1995
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 44 (5) , 570-576
- https://doi.org/10.1016/0026-0495(95)90112-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effect of the new oral antidiabetic agent (−)-BM 13.0913.Na on insulin resistance in lean and obese zucker ratsMetabolism, 1995
- Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in
C 57BL KsJ db db Metabolism, 1991 - Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob miceDiabetes, 1990
- Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic ratsDiabetes, 1983
- Effects of Streptozotocin-induced Diabetes on Insulin Binding, Glucose Transport, and Intracellular Glucose Metabolism in Isolated Rat AdipocytesDiabetes, 1979
- A genetically diabetic model "KK-CAy mice" for a pharmacological assay.Endocrinologia Japonica, 1979
- Laboratory animals exhibiting obesity and diabetes syndromesMetabolism, 1977
- General Survey of Diabetic Features of Yellow KK MiceEndocrinologia Japonica, 1970
- Eine neue Bestimmung der Neutralfette im Blutserum und GewebeJournal of Molecular Medicine, 1966
- Metabolism of Isolated Fat CellsJournal of Biological Chemistry, 1964